The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.
Also called NCT06847568
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,000 participants
- Sponsor
- Registry
-
NCT06847568
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Recruiting
Technical summary
Registry record NCT06847568. Randomized; double masking; primary purpose prevention. Start 2024-04-01 (actual); primary completion 2026-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow
- Condition
- ST Segment Elevation Myocardial Infarction (STEMI)
- Condition
- No Reflow Phenomenon
- Intervention (Drug)
- Adrenaline
- Lead sponsor
- Ain Shams University
Record details
- Record id
cardio:ct-nct06847568- Content hash
a0e1cbe7cd0c552282cd874dc04d96ad4610bbe26469c5bd2ee713219a8830e9